IMMUNOVANT INC (IMVT) Stock Analyst Earnings Estimates
NASDAQ:IMVT - Nasdaq - US45258J1025 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 160.90% | N/A 242.43% | N/A 130.40% | N/A 88.86% | N/A 30.83% | ||||||||
| EBITDA YoY % growth | N/A | -66.06M | -108.05M -63.56% | -155.9M -44.29% | -208.09M -33.48% | -269.978M -29.74% | -437.775M -62.15% | N/A -10.96% | N/A 10.60% | N/A 20.15% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -66.08M | -108.12M -63.62% | -156.03M -44.31% | -208.28M -33.49% | -270.209M -29.73% | -438.152M -62.15% | N/A -16.86% | N/A -13.76% | N/A 21.13% | N/A 78.30% | N/A 1,005.88% | N/A 141.09% | N/A 40.93% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -1.33 | -1.24 6.77% | -1.43 -15.32% | -1.71 -19.58% | -1.90 -11.11% | -2.74 -44.21% | N/A -8.09% | N/A -1.49% | N/A 2.95% | N/A 55.77% | N/A 386.96% | N/A 315.15% | N/A 46.68% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.70 -17.45% | -0.73 1.38% | -0.76 0.28% | -0.78 -21.83% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -113.72M -20.72% | -118.31M -2.37% | N/A | N/A |
| EBIT Q2Q % growth | -122.165M -29.58% | -126.533M -9.32% | -134.118M -17.34% | -140.443M -23.38% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -0.64 -23.08% | -0.73 | 0.09 | 12.44% |
| Q3 2025 Q2Q % growth | -0.76 -111.11% | -0.76 | 0.00 | 0.54% |
| Q2 2025 Q2Q % growth | -0.74 -64.44% | -0.61 | -0.13 | -21.51% |
| Q1 2025 Q2Q % growth | -0.60 -5.26% | -0.54 | -0.06 | -11.53% |
| Q4 2024 Q2Q % growth | -0.52 -13.04% | -0.44 | -0.08 | -19.49% |
| Q3 2024 Q2Q % growth | -0.36 26.53% | -0.44 | 0.08 | 18.17% |
| Q2 2024 Q2Q % growth | -0.45 -9.76% | -0.48 | 0.03 | 6.25% |
| Q1 2024 Q2Q % growth | -0.57 -62.86% | -0.46 | -0.11 | -25.20% |
| Q4 2023 Q2Q % growth | -0.46 -12.20% | -0.44 | -0.02 | -5.41% |
| Q3 2023 Q2Q % growth | -0.49 -36.11% | -0.40 | -0.09 | -23.63% |
| Q2 2023 Q2Q % growth | -0.41 -17.14% | -0.40 | -0.01 | -2.74% |
| Q1 2023 Q2Q % growth | -0.35 -12.90% | -0.40 | 0.05 | 13.29% |
| Q4 2022 Q2Q % growth | -0.41 -41.38% | -0.38 | -0.03 | -6.99% |
| Q3 2022 Q2Q % growth | -0.36 -12.50% | -0.33 | -0.03 | -7.77% |
| Q2 2022 Q2Q % growth | -0.35 -40.00% | -0.29 | -0.06 | -22.55% |
| Q1 2022 Q2Q % growth | -0.31 18.42% | -0.32 | 0.01 | 1.96% |
| Q4 2021 Q2Q % growth | -0.29 23.68% | -0.34 | 0.05 | 14.58% |
| Q3 2021 Q2Q % growth | -0.32 -28.00% | -0.26 | -0.06 | -21.70% |
| Q2 2021 Q2Q % growth | -0.25 34.21% | -0.35 | 0.10 | 27.91% |
| Q1 2021 Q2Q % growth | -0.38 | -0.33 | -0.05 | -13.58% |
| Q4 2020 Q2Q % growth | -0.38 | -0.42 | 0.04 | 9.50% |
| Q3 2020 Q2Q % growth | -0.25 | -0.26 | 0.01 | 3.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.45% | 8.23% | 0% | 5.17% |
| Revenue | N/A | N/A | N/A | N/A |